Paul Duic, M.D.

Paul Duic, M.D., is a Neuro-Oncologist. He specializes in the medical management of brain tumors and spine tumors, including central nervous system (CNS) tumors, gliomas, metastatic tumors, and CNS lymphoma.

Dr. Duic received his undergraduate degree, Bachelor of Sciences, in Biological Sciences, from Columbia University, New York, NY magna cum laude. He obtained his medical degree at NYU School of Medicine, New York, NY.

Dr. Duic completed a Residency in Emergency Medicine at Johns Hopkins University. He also completed a Surgical Internship and three years of Neurological Surgery Residency at UC Davis Medical Center, Sacramento, CA. He subsequently completed a Fellowship in Neuro-Oncology at the Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health (NIH.) He returned to the Neuro-Oncology Branch of NIH before joining Neurological Surgery, P.C.

Dr. Duic has also served as a Lieutenant Commander in the Medical Corps of the United States Naval Reserve.

Dr. Duic published “Central Nervous System Tumors” in the Bethesda Handbook of Clinical Oncology. He has several manuscripts in preparation, including: “Selective Glioma Targeting by a Recombinant Adeno-Associated Virus Type 5 Vector,” and “Phase I Study of CC-8490, a Selective Estrogen Receptor Modulator, in Patients With Recurrent Malignant Gliomas and Progressive, Diffuse, Infi ltrating Gliomas.” He is an experienced co-investigator on multiple clinical trials at NIH involving many novel molecularly targeted agents. He has delivered neurosurgical grand rounds and spoken on several other occasions regarding these clinical trials, such as “The Development of Enzastaurin for Malignant Gliomas.”


“Eltrombopag for the Treatment of Radiation-Induced Thrombocytopenia in a Patient with a Glioblastoma” Duic JP,Grewal J, McConie K, Staszewski H, Haas J, Kesari S. J Neurooncol 2011~ Aug 11.

“Trial of Talampanel, a Glutamate Receptor Inhibitor, for Adults With Recurrent Malignant Gliomas” Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA. Phase 2. Cancer 2010~ Apr 1; 116(7):1776-82.

OmmayaCisternography with Delayed Radiotracer Activity Demonstrated in the Peritoneal Cavity” Scalcione LR, Katz DS, Duic JP, Grewal J, Yung EY. In-111 DTPA. ClinNucl Med. 2009, Dec;34(12):955-7.

“A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas” Kreisl TN, Kim L, Moore K, Duic JP, Kotliarova S, Walling J, Musib L, Thornton D, Albert PS, Fine HA. .
Clin Cancer Res, 2009 May 5

“A Phase II Trial of Single Agent Bevacizumab Followed by BevacizumabPlusIrinotecan at Tumor Progression in Patients with Recurrent Glioblastoma.” Kreisl TN, Kim L, Moore K, Duic JP, Royce C, Stroud I, Garren N, Mackey M, Butman J, Albert PS. JCO 2009 Feb 10; 27(5): 740-5.

Germinoma” Duic JP, Grewal J, Kesari S. Medlink Neurology 2009.

“Spinal Ependymoma” Grewal J, Duic JP, Kesari S. Medlink Neurology 2009.

“A Phase I Trial of Lenalidomide in Patients With Recurrent Primary Central Nervous System Tumors.” Fine HA, Kim L, Albert PS, Duic JP, Ma H, Figg WD, Royce C. Clinical Cancer Research~ 2007;13(23):7101-06.

“Central Nervous System Tumors” Mansky P, Duic JP, Fine HA. In Bethesda Handbook of Clinical Oncology. J. Abraham, C.J. Allegra, and James Gulley (eds), 2nd Edition, Lippincott Williams & Wilkins, In Press, 2004.

Need to make an appointment?




HIGH SCHOOL sweethearts Donald and Melanie Squire of East Northport had just returned home from a relaxing vacation in Aruba. But the couple became concerned when Donald’s eye began to twitch uncontrollably and he experienced a loss of peripheral vision. Suspecting a possible stroke, Melanie, an ICU nurse at Huntington Hospital, called 9-1-1. Donald was…


Inaugural Event to Be Held September 20 at Jones Beach ROCKVILLE, CENTRE, N.Y. – The Long Island Brain Tumor Center at Neurological Surgery, P.C. (NSPC) has been named “Premiere Event Flagship Sponsor” of the National Brain Tumor Society’s inaugural Long Island Brain Tumor Walk.  The walk, which will raise critical funds for brain tumor research…


ROCKVILLE, CENTRE, N.Y. – A recent symposium, co-sponsored by The Long Island Brain Tumor Center at Neurological Surgery, P.C. (NSPC) and St. Francis Hospital – The Heart Center®,  gave approximately 100 New York physicians, physician assistants and nurses a hopeful glimpse into the future of brain cancer treatment.  Held at the hospital’s DeMatteis Center (Greenvale,…